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Abstract Post-cardiac arrest myocardial dysfunction is a
common phenomenon after return of spontaneous circula-
tion (ROSC) and contributes to hemodynamic instability
and low survival rates after cardiac arrest. Mild hypother-
mia for 24 h after ROSC has been shown to significantly
improve neurologic recovery and survival rates. In the
present study we investigate the influence of therapeutic
hypothermia on hemodynamic parameters in resuscitated
patients and on contractility in failing human myocardium.
We analyzed hemodynamic data from 200 cardiac arrest
survivors during the hypothermia period. The initial LVEF
was 32.6 ± 1.2% indicating a significantly impaired LV
function. During hypothermia induction, the infusion rate
of epinephrine could be significantly reduced from 9.1 ±
1.3 lg/min [arrival intensive care unit (ICU) 35.4C] to
4.6 ± 1.0 lg/min (34C) and 2.8 ± 0.5 lg/min (33C).
The dobutamine and norepinephrine application rates were
not changed significantly. The mean arterial blood pressure
remained stable. The mean heart rate significantly
decreased from 91.8 ± 1.7 bpm (arrival ICU) to 77.3 ±
1.5 bpm (34C) and 70.3 ± 1.4 bpm (33C). In vitro we
investigated the effect of hypothermia on isolated ven-
tricular muscle strips from explanted failing human hearts.
With decreasing temperature, the contractility increased to
a maximum of 168 ± 23% at 27C (n = 16, P \ 0.05).
Positive inotropic response to hypothermia was accompa-
nied by moderately increased rapid cooling contractures as
a measure of sarcoplasmic reticulum (SR) Ca2? content,
but can be elicited even when the SR Ca2? release is
blocked in the presence of ryanodine. Contraction and
relaxation kinetics are prolonged with hypothermia, indi-
cating increased Ca2? sensitivity as the main mechanism
responsible for inotropy. In conclusion, mild hypothermia
stabilizes hemodynamics in cardiac arrest survivors which
might contribute to improved survival rates in these
patients. Mechanistically, we demonstrate that hypother-
mia improves contractility in failing human myocardium
most likely by increasing Ca2?-sensitivity.
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Introduction
Survival after cardiac arrest remains low worldwide,
averaging B6% for out-of-hospital [1, 2] and 18% for
in-hospital arrest [1–3]. Even after return of spontaneous
circulation (ROSC) the overall prognosis is poor. The
National Registry of Cardiopulmonary Resuscitation
(NRCPR) reported in 2006 that among 19,819 adults who
regained ROSC, in-hospital mortality was 67% [4]. One
important contributor to the low survival rates after ROSC
is post-cardiac arrest myocardial dysfunction that is well
described in both animal and human studies [5–9]. Mild
hypothermia is the only therapy applied in the post-cardiac
arrest setting that has been shown to significantly improve
survival rates [10, 11]. Therefore, international guidelines
recommend the induction of therapeutic hypothermia
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(32–34C for 12–24 h) in all comatose survivors of cardiac
arrest [12, 13]. Several techniques are available to easily
and safely induce therapeutic hypothermia [10, 12, 14, 15].
By reducing oxygen consumption and numerous deleteri-
ous biochemical and physical mechanisms that lead to
reperfusion cell damage hypothermia reduces brain injury
and improves neurologic recovery [10, 15]. Moreover, in
several animal species [16–19] and nonfailing human
myocardium [16] hypothermia has been shown to directly
increase cardiac contractility. Contradictory, it has been
reported that hypothermia could decrease cardiac output
and increase the requirement of inotropics [15, 20].
In the present study, we systematically analyzed
hemodynamic parameters of cardiac arrest survivors during
the hypothermia period. Mechanistically, we investigated
the effects of hypothermia on contractility and Ca2? han-
dling in isolated ventricular muscle strips from explanted
failing human hearts in vitro.
Methods
Clinical data analysis
We retrospectively analyzed the data from cardiac arrest
patients that were consecutively admitted to the Cardi-
ology Intensive Care Unit (ICU) of the University Heart
Center of Gottingen between January 2005 and December
2008 and treated with mild hypothermia (32–34C).
Patients were included when their records were avail-
able and all study relevant data were documented. 224
patients were screened. 24 patients were excluded
because of missing a significant amount of data. Cardiac
arrest was defined as being unconscious as a result of a
sudden pulseless collapse; ROSC was a return of a
spontaneous palpable pulse. Except for trauma, all causes
of cardiac arrest were considered [21–23]. Out-of-hos-
pital as well as in-hospital cardiac arrest patients were
included. Patients were eligible if they were 18 years and
older. All patients received intensive care interventions
as recommended by ILCOR [12, 13]. The trachea was
intubated and central venous access was established in
all patients. Invasive blood pressure, heart rate (HR) and
pulse oximetry data were monitored continuously. Core
temperature was measured continuously by a bladder
temperature probe (Foley catheter). Hemodynamic sup-
port with inotropic agents or vasopressors was used as
indicated to reach a mean arterial blood pressure (MAP)
of 80 mmHg. The dose of the different catecholamines
(epinephrine, norepinephrine and dobutamine) was
adjusted according to the clinical judgment of the phy-
sician on duty, considering MAP, HR, echocardiography
results, urine production and underlying disease. Invasive
measurements by pulmonary-artery catheter were per-
formed only in some patients, if the hemodynamic situ-
ation deteriorated over time.
If indicated, mechanical devices (intraaortic balloon
pump or microaxial LV-assist device [24–26]) were
implanted in the cath lab before the patients were trans-
ferred to the ICU. Arterial blood gas values were frequently
obtained to adjust the ventilator to maintain an arterial
oxygen saturation of 94–96% and a partial pressure of
arterial carbon dioxide (PaCO2) of 40 mmHg (corrected for
temperature). Left ventricular systolic function was asses-
sed by echocardiography in biplane standard views.
Hypothermia was induced in all patients that remained
unconscious after ROSC. After an initial evaluation of
neurological status, all patients received intravenous
sedation (midazolam or propofol and fentanyl or sufenta-
nil). To prevent shivering, paralysis was induced by
intravenous administration of pancuronium. All patients
were cooled with external cool packs and cold infusions,
starting right after arrival in the emergency room. In
addition, 38 patients received an intravascular cooling
catheter (CoolGuard, Alsius) and 28 patients were placed
in a cooling tent (DeltaTherm, KCI). Cooling catheter and
cooling tent were implemented when the patients arrived at
the ICU. Hypothermia induction was continued during
diagnostic or therapeutic procedures such as percutaneous
coronary intervention (PCI) or computed tomography (CT)
scan. The target temperature of 33C was maintained for
24 h while the patient continued to be sedated and para-
lyzed. After 24 h the patient was rewarmed passively and
cautiously (B0.25C/h). Sedation was stopped at a core
temperature of 35C.
We systematically reviewed the patients’ records with
respect to baseline characteristics, body core temperature,
hemodynamic parameters, hemodynamic interventions,
echocardiography results and timings of post-cardiac arrest
procedures. Since patients’ weight is often unknown in the
post-cardiac setting catecholamine doses are presented as
lg/min at certain time points.
In vitro experiments in isolated failing human
myocardium
Experiments were performed in ventricular myocardium
from human hearts obtained from patients with end-stage
heart failure undergoing heart transplantation. The study
protocol was reviewed and approved by the ethical
committee and were in accordance with institutional
guidelines. Preparation of muscle strips was performed as
described previously [27, 28]. Briefly, immediately after
explantation of the hearts, the ventricles were stored in
cooled, modified Krebs-Henseleit buffer (KHB) that
contained (in mmol/L): Na? 152, K? 3.6, Cl- 135,
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HCO3
- 25, Mg2? 0.6, H2PO4
- 1.3, SO4
2- 0.6, Ca2? 2.5,
glucose 11.2, and insulin 10 IU/L. The KHB was con-
tinuously bubbled with carbogen (95% O2/5% CO2) to
adjust the pH to 7.4. In addition, the KHB contained
30 mmol/L 2,3-butanedione monoxime (BDM) to protect
the myocardium during transportation and from injury as
a result of cutting at the time of muscle strip dissection
[29]. Thin ventricular trabeculae (diameter \0.6 mm)
were dissected with the help of a stereoscopic micro-
scope. All preparation steps were carried out in the
cardioprotective BDM solution. For the mechanical
measurements, the muscle strips were transferred to an
organ chamber and connected to the force gauge by
using fine steel hooks (F30 type 372, Hugo Sachs
Elektronik). The muscle strips were submerged in the
modified KHB (composition given above) without BDM
at 37C. Isometric twitches were evoked by electrical
stimulation with a stimulation frequency of 1 Hz (stim-
ulation voltage 25% above threshold). The muscle strips
were initially pre-stretched with 1 mN and allowed to
equilibrate for 30 min. Thereafter, the muscle strips were
gradually stretched until maximum steady-state twitch
force was reached (Lmax). To investigate SR Ca
2? con-
tent, rapid cooling contractures (RCCs) were elicited at
steady-state conditions as previously described [27]. On
cooling from 37 to 1C, all Ca2? from the SR is
released, which leads to a stable contracture of the
muscles, because all Ca2? transport systems are blocked
by the low temperature. The amplitude of the contracture
reflects the SR Ca2? content. Twitch force and RCCs
were measured at temperatures of 37, 35, 33, 31 and
27C under steady-state conditions at a stimulation fre-
quency of 1 Hz. It is important to note that RCCs are
contractures induced by an acute rapid temperature jump
to 1C and are used as a semiquantitative index of SR
Ca2? availability. These RCCs should not be confused
with increase in stimulated twitch tension that is brought
by less dramatic changes in steady-state temperature
(37–27C).
To further investigate the role of the SR in the contri-
bution to the inotropic effect of hypothermia, we used a
protocol in which SR Ca2? storage function was com-
pletely blocked by ryanodine (1 lmol/L) added to the
perfusate [17]. RCCs were again performed to check the
effectiveness of this protocol. Approximately 20 min after
application of ryanodine force stabilized on a new baseline
that was characterized by decreased developed force,
increased diastolic force, and prolonged twitch-timing. The
absence of any RCCs confirmed a complete blockage of SR
Ca2? handling. Hypothermia was applied again, and the
inotropic response was recorded under blocked SR Ca2?
storage function. Due to the length of the experimental
protocols all experiments where run-down corrected for
each muscle strip and presented as percentage (%) of
change in force of contraction.
Statistical analysis
All values are presented as mean ± SEM. Differences
between values were evaluated for statistical significance
by use of ANOVA followed by Tukey’s post test analysis.
Correlations were examined by linear regression analysis.
The significance level was set at P \ 0.05.
The authors had full access to and take full responsi-
bility for the integrity of the data. All authors have read and
agreed to the manuscript as written.
Results
Baseline characteristics of the patients
We retrospectively analyzed the data of 200 consecutive
cardiac arrest patients between January 2005 and Decem-
ber 2008. The average age of the enrolled patients was
64.5 ± 1.0 years (range 18–100 years). 76% of the cases
were out-of hospital arrests. Most patients presented with
ventricular fibrillation (53.5%) as the initial cardiac
rhythm; 34% of the patients had asystole, 9% PEA. The
predominant cause of cardiac arrest was acute myocardial
infarction (46.5%) followed by primary arrhythmias in
patients with ischemic heart disease (13.5%) or other car-
diomyopathies (14%). A significantly reduced systolic left
ventricular function (LV) with an initial ejection fraction
(EF) of 32.6 ± 1.2% (range 10–65%) was documented by
echocardiography. In 75 patients (38%) an intraaortic
balloon pump was implanted. 6 patients (3%) received a
microaxial LV-assist device. In-hospital mortality was
45.5%. The detailed baseline characteristics are presented
in Table 1.
Cooling and hemodynamic data
The average time interval from admission to our hospital to
ICU arrival was 112.6 ± 10.0 min (Table 2). The main
reasons for this delay were procedures such as diagnostic
coronary angiography (59%), PCI (40%) or CT scans
(11%). Since cooling was started in the emergency room
(ER) and continued during the interventions such as PCI,
the initial core temperature (bladder temperature probe) on
ICU arrival was already 35.4 ± 0.1C. Body temperatures
of 34 and 33C were achieved 4.1 ± 0.3 and 7.1 ± 0.5 h
after admission to the ICU, respectively.
During induction of therapeutic hypothermia, the
hemodynamic support by epinephrine infusion could be
reduced from 9.1 ± 1.3 lg/min (arrival ICU) to 4.6 ±
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1.0 lg/min (34C, P \ 0.05) and 2.8 ± 0.5 lg/min (33C,
P \ 0.05, Fig. 1a). At the same time, the application rate
of the vasoconstrictor norepinephrine did not significantly
change (arrival ICU: 5.3 ± 1.0 lg/min, 34C: 7.1 ±
0.9 lg/min, 33C: 7.5 ± 0.9 lg/min, P = 0.16, Fig. 1b).
The infusion rate of dobutamine was not changed (arrival
ICU: 0.3 ± 0.1 mL/h; 34C: 0.4 ± 0.1 mL/h; 33C: 0.5 ±
0.1 mL/h; P = 0.23, Fig. 1c). Despite reduced epinephrine
dosage, the MAP remained stable at 82.7 ± 1.6 mmHg
(arrival ICU), 80.7 ± 1.2 mmHg (34C) and 78.4 ±
1.2 mmHg (33C, P = 0.09, Fig. 2a). The mean HR sig-
nificantly decreased from 91.8 ± 1.7 bpm (arrival ICU) to
77.3 ± 1.5 bpm (34C, P \ 0.05) and 70.3 ± 1.4 bpm
(33C, P \ 0.05, Fig. 2b).
During the hypothermia maintenance period (24 h at
33C) the catecholamine dosages were not changed
significantly (Fig. 1). During re-warming, the infusion
rate of norepinephrine slightly increased (P = 0.16),
whereas epinephrine and dobutamine remained stable
(Fig. 1).
Table 1 Baseline characteristics
Total no. of patients 200
Male sex, no. (%) 149 (74.5)
Female sex, no. (%) 51 (25.5)
Age, years 64.5 ± 1.0
Out-of-hospital arrest, no. (%) 151 (75.5)
Initial cardiac rhythm
Ventricular fibrillation or tachycardia, no. (%) 107 (53.5)
Asystole, no. (%) 68 (34)
Pulseless electrical activity, no. (%) 18 (9)
Not reported, no. (%) 7 (3.5)
Diagnosis or cause of cardiac arrest
Myocardial infarction, no. (%) 93 (46.5)
Primary arrhythmia (CAD and reduced EF), no. (%) 27 (13.5)
Primary arrhythmia (other cardiomyopathy), no. (%) 28 (14)
Pulmonary embolism, no. (%) 9 (4.5)
Other, no. (%) 43 (21.5)
Initial LV ejection fraction, % 32.6 ± 1.2
no number, LV left ventricular, CAD coronary artery disease, EF
ejection fraction
Table 2 Cooling parameters
Time interval from ER admission to arrival ICU, min 112.6 ± 10.0
Reason for delay
Coronary angiography, no. (%) 118 (59)
Percutaneous coronary intervention (PCI), no. (%) 79 (40)
CT scan, no. (%) 22 (11)
Echocardiography, no. (%) 64 (32)
Initial body temperature at arrival ICU, C 35.4 ± 0.1
Time interval from arrival ICU to target temperature
To 34C, h 4.1 ± 0.3
To 33C, h 7.1 ± 0.5
ER emergency room, ICU intensive care unit, no number, CT com-
puter tomography
Fig. 1 Hemodynamic support by catecholamines during induction of
therapeutic hypothermia (on arrival at the intensive care unit (ICU), at
34 and 33C body temperature) and during the re-warming period
(after 24 h at 33C and after reaching 36.5C): a infusion rate of
epinephrine. *P \ 0.05 versus arrival ICU. b Infusion rate of
norepinephrine. c Infusion rate of dobutamine
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40% of the patients were treated with PCI before they
were transferred to the ICU. To exclude the hemodynamic
effect of myocardial recovery due to PCI we analyzed the
data of all patients not treated with PCI. The results in this
subgroup did not differ from the whole study population
(Figs. 5, 6, online data supplement).
The efficacy of catecholamines can be impaired by
acidosis. Therefore, we analyzed the arterial pH values
during hypothermia induction. At arrival to the ICU the pH
value was 7.30 ± 0.01, indicating a mild acidosis. With
hypothermia induction the pH increased to 7.39 ± 0.01 at
34C and 7.40 ± 0.01 at 33C (P \ 0.05 vs. arrival ICU,
Fig. 7, online data supplement).
Effect of hypothermia on contractility of isolated
failing human myocardium
Ventricular myocardium from human hearts was obtained
from 15 patients with end-stage failing dilated (n = 6) or
ischemic (n = 9) cardiomyopathy undergoing heart trans-
plantation. Mean age of the patients was 55.5 ± 2.2 years,
and mean EF was 23.5 ± 1.7%; 5 patients were women.
Detailed clinical data of these patients including medica-
tions are shown in Table 3 (online data supplement).
In failing human myocardium hypothermia induced a
temperature-dependent increase in force of contraction,
reaching statistical significance at 33C and lower. Fig-
ure 3a demonstrates that a stepwise reduction in bath
temperature from 37 to 27C resulted in a maximal
increase in force of contraction to 167.5 ± 23.0%
(P \ 0.05 vs. 37C, n = 16).
To further elucidate the subcellular mechanism of the
inotropic effect of hypothermia, RCC experiments were
performed. By cooling the myocardium rapidly to 1C, all
SR Ca2? is released leading to a stable contracture that is
indicative of the SR Ca2? content. By step wisely lowering
the baseline temperature from 37 to 27C RCC amplitudes
increased to a maximum of 145.2 ± 8.4% at 27C
(P \ 0.05 vs. 37C, n = 16, Fig. 3b). This suggests that
hypothermia increases SR Ca2? content in failing human
myocardium.
To further investigate the contribution of the SR to the
inotropic effects of hypothermia, SR function was inhibited
by ryanodine. Under SR blockade hypothermia still
increases contraction force amplitudes, reaching
145.1 ± 13.6% at 31C (P \ 0.05, n = 13, data not
shown). Interestingly, at 27C the contraction force
amplitude slightly decreased to 93.9 ± 17.0% (n = 13).
This is caused by a pronounced increase of the diastolic
force at 27C, exceeding the increase in systolic force
(Fig. 3c). However, in the temperature range from 37 to
31C the inotropic response to hypothermia was still
observed after blockade of SR function with ryanodine. A
linear regression analysis reveals that—excluding the 27C
values—there is a linear correlation between the contrac-
tion force with and without ryanodine (r = 0.75,
r2 = 0.57, Fig. 3d) between 37 and 31C. This indicates
that the SR is not the main contributor to the positive
inotropic effect of hypothermia.
Figure 4 demonstrates the influence of hypothermia on
contraction and relaxation kinetics. The positive inotropic
effect of hypothermia is associated with a significant
increase in time to peak tension (TTP), total twitch time
(TTT) and time to 50 and 90% relaxation (RT 50 and RT
90) typical for an increase in myofilament Ca2? sensitivity.
This prolongation in contraction and relaxation times was
even more pronounced in the presence of ryanodine.
Fig. 2 Hemodynamic parameters during induction of therapeutic
hypothermia (on arrival at the intensive care unit (ICU), at 34 and
33C body temperature) and re-warming (after 24 h at 33C and after
reaching 36.5C). a MAP mean arterial blood pressure. *P \ 0.05
versus arrival ICU, 34 and 33C. b HR heart rate. *P \ 0.05 versus
arrival ICU, P \ 0.05 versus 34C, #P \ 0.05 versus 34, 33 and
33C (24 h)
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Discussion
The present study demonstrates that mild hypothermia
improves hemodynamics in cardiac arrest survivors. In
isolated failing human myocardium hypothermia signifi-
cantly increases contractility. Positive inotropic response to
hypothermia is accompanied by moderately increased SR
Ca2? content but can be elicited even when the SR Ca2?
storage function is blocked. Contraction and relaxation
kinetics are prolonged with hypothermia, indicating
increased Ca2? sensitivity of the myofilaments as the main
mechanism for inotropy.
Hypothermic inotropism has been shown previously in
several animal studies [16–19]. In 1897, Langendorff [18]
was the first to describe a relation between temperature and
myocardial function. Moreover, hypothermia has been
shown to increase contractility in nonfailing human myo-
cardium [16]. However, in the failing human heart, Ca2?
cycling, contractile function and their response to external
interventions are significantly altered compared to non-
failing hearts [27, 30, 31]. Intriguingly, we now demon-
strate that mild hypothermia improves contractility also in
failing human myocardium. Furthermore, in cardiac arrest
survivors presenting with impaired LV function, induction
of therapeutic hypothermia was associated with signifi-
cantly reduced epinephrine requirement indicating hemo-
dynamic stabilization. Since the arterial pH increased from
7.30 (arrival ICU) to 7.39 (34C), it cannot be excluded
that the pH shift contributes to the reduced epinephrine
requirement. However, a pH of 7.30 indicates a very mild
acidosis and by reducing the body temperature from 34 to
33C the pH is not affected whereas the epinephrine dose
could be further reduced from 4.6 to 2.8 lg/min.
In the study of Bernard et al. [15] the cardiac index (CI)
decreased in hypothermia versus normothermia treated
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Fig. 3 Effect of hypothermia
on contractility and Ca2?
handling in isolated muscle
strips from failing human
myocardium. a Change in force
of contraction during stepwise
cooling from 37 to 27C.
Stimulation frequency: 1 Hz.
Average values from 16 muscle
strips given in percent of the
control value at 37C.
*P \ 0.05 versus control
(37C). b Influence of
temperature on rapid cooling
contractures (RCC). Changes in
the amplitude of RCCs upon
cooling are given in percent of
the control value at 37C.
Average values from 16 muscle
strips. *P \ 0.05 versus control
(37C). c Effect of ryanodine on
systolic and diastolic force
during mild hypothermia.
Average values from 13 muscle
strips. *P \ 0.05 versus control
(37C). d Correlation of change
in force of contraction during
hypothermia with and without
ryanodine. 27C values were
excluded since diastolic force
increased excessively at 27C.
Scatter plot with linear
regression analysis and 95%
confidence interval. r = 0.75,
r2 = 0.57
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resistance (SVR) was significantly increased in these
patients, which might explain the reduced cardiac output.
In pigs mild hypothermia increased CI without signifi-
cantly affecting SVR [16]. Higher incidence of required
epinephrine infusions in the study of Bernard et al. [15]
includes the rewarming period and does therefore not argue
against our results.
To elucidate the subcellular effects of mild hypo-
thermia, we performed RCC measurements in muscle
strips from failing human myocardium. In contrast to
previous data from pig myocardium [16], mild hypo-
thermia moderately increased RCC amplitudes indicating
that SR Ca2? content may be increased. One could
speculate that increased SR Ca2? load may be associated
with subsequent enhanced SR Ca2? release. However,
the inotropic response to hypothermia was still observed
after complete blockade of SR function with ryanodine.
This finding is in line with experimental data from
Shattock and Bers [17], indicating that mechanisms,
other than those involving the SR, contribute to the
hypothermia-induced inotropism. One possibility is
increased Ca2? sensitivity. In the present study, hypo-
thermia prolonged both contraction and relaxation times,
indicating increased Ca2? responsiveness of the myofil-
aments as an important underlying mechanism of posi-
tive inotropism [32]. Increased Ca2? sensitivity might
result from hypothermia-induced alkalosis [33, 34] or
slowed cross-bridge cycling rate [35].
While systolic performance is clearly improved at all
temperature steps investigated, increasing myofilament
Ca2? sensitivity might induce diastolic dysfunction [36].
In the present study, we observed an increase in diastolic
force at 27C particularly when SR function was inhib-
ited by ryanodine, indicating that pronounced hypother-
mia might impair diastolic function. This has important
implications for the treatment of successfully resuscitated
patients, since diastolic dysfunction is a common phe-
nomenon after ROSC [37–40]. However, in the temper-
ature range recommended for therapeutic hypothermia in
cardiac arrest patients (32–34C) [12, 13], we did not
observe any relevant changes in diastolic function. Fur-
thermore, our clinical data demonstrate that hypothermia
significantly reduces HR, an intervention that usually
improves LV filling [41]. However, since optimal cool-
ing temperature is still under investigation, it should
be considered that temperatures below the current
Fig. 4 Influence of
hypothermia on contraction and
relaxation kinetics. Average
values from 13 muscle strips
with and 16 muscle strips
without ryanodine (Rya).
Stimulation frequency: 1 Hz.
*P \ 0.05 versus control
(37C). #P \ 0.05 with
ryanodine versus without
ryanodine (37C). a Time to
peak tension (TTP), b total
twitch time (TTT), c time to
50% relaxation (RT 50), d time
to 90% relaxation (RT 90)
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recommendations might induce or worsen diastolic heart
failure.
Post-cardiac arrest myocardial dysfunction is responsive
to inotropic drugs [39, 42]. In swine, dobutamine infusions
of 5–10 lg(kg min) substantially improve systolic and
diastolic function after cardiac arrest [39]. However, cAMP
dependent inotropes such as b-adreno-agonists or phos-
phodiesterase III inhibitors, increase myocardial oxygen
consumption, can exacerbate or induce ischemia in patients
with coronary artery disease, can exert direct cardiac tox-
icity and have consistently been proven to increase mor-
tality in chronic heart failure [43–45]. As discussed above,
hypothermia most likely acts by sensitizing the myofila-
ments for Ca2?. In contrast to cAMP elevating inotropes,
hypothermia prolongs contraction and relaxation times,
acts partially independently of SR function and signifi-
cantly reduces HR. Therefore, it may favorably impact
myocardial energetics relative to traditional inotropic
therapies. Animal studies have shown that in myocardial
infarction hypothermia decreases oxygen consumption and
infarct size [46, 47]. Preliminary data indicate that mild
hypothermia might represent an attractive approach to
increase contractility not only after cardiac arrest but also
in other patients with cardiogenic shock [48].
Our clinical data demonstrate that hypothermia signifi-
cantly reduces HR. In this context, it is important to note
that the force-frequency relation is inversed during hypo-
thermia. Lewis et al. [49] have nicely shown that higher
HRs result in reduced contractility at colder temperatures.
Therefore, lower HRs are beneficial during hypothermia.
This study has some limitations. Due to the hemody-
namic stabilization during hypothermia induction, invasive
hemodynamic measurements by pulmonary catheter were
not performed routinely. Therefore, invasive hemodynamic
data cannot be provided.
There was no normothermia control group of resusci-
tated patients with which to compare changes in hemody-
namic parameters. Since post-cardiac arrest myocardial
dysfunction is a potentially reversible phenomenon [6, 7,
50], we cannot completely exclude that hemodynamic
stabilization might occur independently of hypothermia
induction. However, Bernard et al. [15] described no
increase of CI values in the normothermia group during the
first 6 h after admission to the ICU. Moreover, it has been
reported that CI values reach their nadir at 8 h after
resuscitation [6]. In contrast, we observed a significant
reduction in epinephrine requirement within 6 h, indicating
an accelerated improvement of hemodynamics by induc-
tion of hypothermia. Furthermore, our in vitro experiments
were performed in a control-matched setting, demonstrat-
ing that hypothermia instantly increases contractility in one
and the same failing myocardial muscle strip.
During the re-warming period, the catecholamine
doses were not changed significantly. However, the re-
warming period could not be compared with the cooling
induction for several reasons: (1) as mentioned above,
post-cardiac arrest myocardial dysfunction reaches its
nadir 8 h after ROSC. Contractility is known to recover
after 24 h [6]. Therefore, it is not surprising that the
requirement for epinephrine and dobutamine did not rise
again. (2) As recommended [12], hypothermia was
induced as rapid as possible, whereas re-warming was
performed very slowly (0.2C/h). A body temperature of
36.5C was reached after 18.7 h (almost 3 times slower
than cooling induction). This is a long time for com-
pensatory mechanisms. (3) Induction and maintenance of
therapeutic hypothermia were performed under constantly
deep sedation. During the re-warming period sedation
was stopped after reaching 35C. Increasing vigilance
will likely interfere with the need for catecholamines. (4)
Normothermia was reached approximately 48 h after
ROSC. At this time point many of the ventilated cardiac
arrest patients are affected by infections and sepsis that
will influence the hemodynamic situation.
Hemodynamic instability as part of the post-cardiac
arrest syndrome is not only caused by myocardial dys-
function, but also a severe systemic ischemia/reperfusion
response, having many characteristics in common with
sepsis, i.e. systemic inflammation, endothelial activation,
impaired vasoregulation and intravascular volume deple-
tion [12, 51–54]. In the present study, we demonstrate that
mild hypothermia increases contractility in failing human
myocardium. This effect most likely contributes to the
early hemodynamic stabilization we observed in cardiac
arrest survivors treated with hypothermia. However, since
hypothermia has been reported to increase SVR [15], this
might also help to stabilize the hemodynamic situation in
the post-cardiac arrest syndrome. In our study population
the application rate of the vasopressor norepinephrine was
slightly but not significantly increased during hypothermia
induction and re-warming.
In conclusion, mild hypothermia stabilizes hemody-
namics in cardiac arrest survivors, which might contribute
to improved survival rates in these patients. As one pos-
sible mechanism we demonstrate that hypothermia
increases contractility in the failing human myocardium
most likely by increasing Ca2? sensitivity. Further studies
are required to evaluate hypothermia as inotropic inter-
vention in patients with cardiogenic shock.
Acknowledgments Dr. Maier is funded by the Deutsche Fors-
chungsgemeinschaft (DFG) through grants for a Clinical Research
group KFO155 (MA 1982/2-2) and a Heisenberg grant (MA 1982/4-1),
as well as by the Deutsche Gesellschaft fu¨r Kardiologie (DGK) by a
Hengstberger grant.
274 Clin Res Cardiol (2010) 99:267–276
123
Conflict of interest statement The authors declare that they have
no conflicts of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Fredriksson M, Herlitz J, Nichol G (2003) Variation in outcome
in studies of out-of-hospital cardiac arrest: a review of studies
conforming to the Utstein guidelines. Am J Emerg Med 21:276–
281
2. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL,
Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D,
Idris A, Stiell I (2008) Regional variation in out-of-hospital
cardiac arrest incidence and outcome. JAMA 300:1423–1431
3. Ehlenbach WJ, Barnato AE, Curtis JR, Kreuter W, Koepsell TD,
Deyo RA, Stapleton RD (2009) Epidemiologic study of in-hos-
pital cardiopulmonary resuscitation in the elderly. N Engl J Med
361:22–31
4. Nadkarni VM, Larkin GL, Peberdy MA, Carey SM, Kaye W,
Mancini ME, Nichol G, Lane-Truitt T, Potts J, Ornato JP, Berg
RA, for the National Registry of Cardiopulmonary Resuscitation
Investigators (2006) First documented rhythm and clinical out-
come from in-hospital cardiac arrest among children and adults.
JAMA 295:50–57
5. Gazmuri RJ, Weil MH, Bisera J, Tang W, Fukui M, McKee D
(1996) Myocardial dysfunction after successful resuscitation
from cardiac arrest. Crit Care Med 24:992–1000
6. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bour-
geois B, Cariou A, Rozenberg A, Carli P, Weber S, Dhainaut JF
(2002) Reversible myocardial dysfunction in survivors of out-of-
hospital cardiac arrest. J Am Coll Cardiol 40:2110–2116
7. Ruiz-Bailen M, de guayo HE, Ruiz-Navarro S, az-Castellanos
MA, Rucabado-Aguilar L, Gomez-Jimenez FJ, Martinez-Escobar
S, Moreno RM, Fierro-Roson J (2005) Reversible myocardial
dysfunction after cardiopulmonary resuscitation. Resuscitation
66:175–181
8. Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A,
Holmberg S (1995) Hospital mortality after out-of-hospital car-
diac arrest among patients found in ventricular fibrillation.
Resuscitation 29:11–21
9. Laver S, Farrow C, Turner D, Nolan J (2004) Mode of death after
admission to an intensive care unit following cardiac arrest.
Intensive Care Med 30:2126–2128
10. The Hypothermia after Cardiac Arrest Study Group (2002) Mild
therapeutic hypothermia to improve the neurologic outcome after
cardiac arrest. N Engl J Med 346:549–556
11. Holzer M, Bernard SA, Hachimi-Idrissi S, Roine RO, Sterz F,
Mullner M (2005) Hypothermia for neuroprotection after cardiac
arrest: systematic review and individual patient data meta-anal-
ysis. Crit Care Med 33:414–418
12. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger
BW, Callaway C, Clark RSB, Geocadin RG, Jauch EC, Kern KB,
Laurent I, Longstreth WT Jr, Merchant RM, Morley P, Morrison
LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A,
Sellke FW, Spaulding C, Sunde K, Vanden Hoek T (2008) Post-
Cardiac Arrest Syndrome: Epidemiology, Pathophysiology,
Treatment, and Prognostication A Consensus Statement From the
International Liaison Committee on Resuscitation (American
Heart Association, Australian and New Zealand Council on
Resuscitation, European Resuscitation Council, Heart and Stroke
Foundation of Canada, InterAmerican Heart Foundation, Resus-
citation Council of Asia, and the Resuscitation Council of
Southern Africa); the American Heart Association Emergency
Cardiovascular Care Committee; the Council on Cardiovascular
Surgery and Anesthesia; the Council on Cardiopulmonary, Peri-
operative, and Critical Care; the Council on Clinical Cardiology;
and the Stroke Council. Circulation 118:2452–2483
13. International Liaison Committee on Resuscitation (2005) Pro-
ceedings of the 2005 international consensus on cardiopulmonary
resuscitation and emergency cardiovascular care science with
treatment recommendations. Resuscitation 67:157–341
14. Storm C, Schefold JC, Kerner T, Schmidbauer W, Gloza J,
Krueger A, Jorres A, Hasper D (2008) Prehospital cooling with
hypothermia caps (PreCoCa): a feasibility study. Clin Res Car-
diol 97:768–772
15. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W,
Gutteridge G, Smith K (2002) Treatment of comatose survivors
of out-of-hospital cardiac arrest with induced hypothermia.
N Engl J Med 346:557–563
16. Weisser J, Martin J, Bisping E, Maier LS, Beyersdorf F,
Hasenfuss G, Pieske B (2001) Influence of mild hypothermia on
myocardial contractility and circulatory function. Basic Res
Cardiol 96:198–205
17. Shattock MJ, Bers DM (1987) Inotropic response to hypothermia
and the temperature-dependence of ryanodine action in isolated
rabbit and rat ventricular muscle: implications for excitation–
contraction coupling. Circ Res 61:761–771
18. Langendorff O (1897) Untersuchungen am u¨berlebenden Sa¨uge-
tierherzen. U¨ber den Einfluss von Wa¨rme und Ka¨lte auf das Herz
der warmblu¨tigen Tiere. Pflugers Arch 355–400
19. Sprung J, Stowe DF, Kampine JP, Bosnjak ZJ (1994) Hypo-
thermia modifies anesthetic effect on contractile force and Ca2?
transients in cardiac Purkinje fibers. Am J Physiol 267:H725–
H733
20. Goetzenich A, Schroth SC, Emmig U, Autschbach R, Pieske B,
Rossaint R, Christiansen S (2009) Hypothermia exerts negative
inotropy in human atrial preparations: in vitro-comparison to
rabbit myocardium. J Cardiovasc Surg (Torino) 50:239–245
21. Herren T, Gerber PA, Duru F (2009) Arrhythmogenic right
ventricular cardiomyopathy/dysplasia: a not so rare ‘‘disease of
the desmosome’’ with multiple clinical presentations. Clin Res
Cardiol 98:141–158
22. Nalenz C, Konradi D, Blank R, Rupprecht HJ (2007) 58-year-old
patient with cardiac arrest due to coronary spasm. Clin Res
Cardiol 96:824–828
23. Strauss M, Gitt AK, Becker T, Kleemann T, Schiele R, Darius H,
Junger C, Senges J, Seidl K (2008) Prehospital cardiac arrest: a
marker for higher mortality in patients with acute myocardial
infarction and moderately reduced left ventricular function:
results from the MITRA plus registry. Clin Res Cardiol 97:748–
752
24. Jung C, Ferrari M, Rodiger C, Fritzenwanger M, Figulla HR
(2008) Combined impella and intra-aortic balloon pump support
to improve macro- and microcirculation: a clinical case. Clin Res
Cardiol 97:849–850
25. Lam K, Sjauw KD, Henriques JP, Ince C, de Mol BA (2009)
Improved microcirculation in patients with an acute ST-elevation
myocardial infarction treated with the Impella LP2.5 percutane-
ous left ventricular assist device. Clin Res Cardiol 98:311–318
26. Jung C, Rodiger C, Fritzenwanger M, Schumm J, Lauten A,
Figulla HR, Ferrari M (2009) Acute microflow changes after stop
and restart of intra-aortic balloon pump in cardiogenic shock.
Clin Res Cardiol 98:469–475
Clin Res Cardiol (2010) 99:267–276 275
123
27. Pieske B, Maier LS, Bers DM, Hasenfuss G (1999) Ca2? han-
dling and sarcoplasmic reticulum Ca2? content in isolated failing
and nonfailing human myocardium. Circ Res 85:38–46
28. Sossalla S, Wagner S, Rasenack ECL, Ruff H, Weber SL,
Scho¨ndube FA, Tirilomis T, Tenderich G, Hasenfuss G, Belard-
inelli L, Maier LS (2008) Ranolazine improves diastolic dys-
function in isolated myocardium from failing human hearts—role
of late sodium current and intracellular ion accumulation. J Mol
Cell Cardiol 45:32–43
29. Mulieri LA, Hasenfuss G, Ittleman F, Blanchard EM, Alpert NR
(1989) Protection of human left ventricular myocardium from
cutting injury with 2, 3-butanedione monoxime. Circ Res
65:1441–1449
30. Hasenfuss G, Pieske B (2002) Calcium cycling in congestive
heart failure. J Mol Cell Cardiol 34:951–969
31. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J,
Holubarsch C, Posival H, Just H, Drexler H (1994) Relation
between myocardial function and expression of sarcoplasmic
reticulum Ca(2?)-ATPase in failing and nonfailing human
myocardium. Circ Res 75:434–442
32. Blinks JR, Endoh M (1986) Modification of myofibrillar
responsiveness to Ca?? as an inotropic mechanism. Circulation
73:III85–III98
33. Churcott CS, Moyes CD, Bressler BH, Baldwin KM, Tibbits GF
(1994) Temperature and pH effects on Ca2? sensitivity of
cardiac myofibrils: a comparison of trout with mammals. Am
J Physiol 267:R62–R70
34. Fabiato A, Fabiato F (1978) Effects of pH on the myofilaments
and the sarcoplasmic reticulum of skinned cells from cardiac and
skeletal muscles. J Physiol 276:233–255
35. Henderson AH, Cattell MR (1976) Length-induced changes in
activation during contraction. A study of mechanical oscillations
in strontium-mediated contractions of cat and frog heart muscle.
Circ Res 38:289–296
36. Abraham TP, Jones M, Kazmierczak K, Liang HY, Pinheiro AC,
Wagg CS, Lopaschuk GD, Szczesna-Cordary D (2009) Diastolic
dysfunction in familial hypertrophic cardiomyopathy transgenic
model mice. Cardiovasc Res 82:84–92
37. Kern KB, Berg RA, Hilwig RW, Larson DF, Gaballa MA (2008)
Myocardial cytokine IL-8 and nitric oxide synthase activity
during and after resuscitation: preliminary observations in regards
to post-resuscitation myocardial dysfunction. Resuscitation
77:401–409
38. McCaul CL, McNamara P, Engelberts D, Slorach C, Hornberger
LK, Kavanagh BP (2006) The effect of global hypoxia on
myocardial function after successful cardiopulmonary resuscita-
tion in a laboratory model. Resuscitation 68:267–275
39. Kern KB, Hilwig RW, Berg RA, Rhee KH, Sanders AB, Otto
CW, Ewy GA (1997) Postresuscitation left ventricular systolic
and diastolic dysfunction: treatment with dobutamine. Circulation
95:2610–2613
40. Hettwer S, Panzner-Grote B, Witthaut R, Werdan K (2007) Iso-
lated diastolic dysfunction–diagnostic value of tissue Doppler
imaging, colour M-mode and N-terminal pro B-type natriuretic
peptide. Clin Res Cardiol 96:874–882
41. Reil JC, Bohm M (2007) The role of heart rate in the develop-
ment of cardiovascular disease. Clin Res Cardiol 96:585–592
42. Huang L, Weil MH, Tang W, Sun S, Wang J (2005) Comparison
between dobutamine and levosimendan for management of pos-
tresuscitation myocardial dysfunction. Crit Care Med 33:487–491
43. Felker GM, O’Connor CM (2001) Inotropic therapy for heart
failure: an evidence-based approach. Am Heart J 142:393–401
44. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R,
Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML
(1991) Effect of oral milrinone on mortality in severe chronic
heart failure. The PROMISE Study Research Group. N Engl J
Med 325:1468–1475
45. Overgaard CB, Dzavik V (2008) Inotropes and vasopressors:
review of physiology and clinical use in cardiovascular disease.
Circulation 118:1047–1056
46. Miki T, Liu GS, Cohen MV, Downey JM (1998) Mild hypo-
thermia reduces infarct size in the beating rabbit heart: a practical
intervention for acute myocardial infarction? Basic Res Cardiol
93:372–383
47. Kuhn LA, Apter R, Weinrauch H, Jacobson TE, Meltzer L (1963)
Hemodynamic and metabolic effects of skin and blood-stream
cooling in experimental myocardial infarction with shock. Am J
Cardiol 12:795–801
48. Schmidt-Schweda S, Ohler A, Grothe A, Pieske B (2004) Mild
hypothermia in cardiogenic shock (COOL-SHOCK). Eur Heart J
25(Suppl 1):653–654
49. Lewis ME, Al-Khalidi AH, Townend JN, Coote J, Bonser RS
(2002) The effects of hypothermia on human left ventricular
contractile function during cardiac surgery. J Am Coll Cardiol
39:102–108
50. Vasquez A, Kern KB, Hilwig RW, Heidenreich J, Berg RA, Ewy
GA (2004) Optimal dosing of dobutamine for treating post-
resuscitation left ventricular dysfunction. Resuscitation 61:199–
207
51. Adrie C, dib-Conquy M, Laurent I, Monchi M, Vinsonneau C,
Fitting C, Fraisse F, nh-Xuan AT, Carli P, Spaulding C, Dhainaut
JF, Cavaillon JM (2002) Successful cardiopulmonary resuscita-
tion after cardiac arrest as a ‘‘sepsis-like’’ syndrome. Circulation
106:562–568
52. Karimova A, Pinsky DJ (2001) The endothelial response to
oxygen deprivation: biology and clinical implications. Intensive
Care Med 27:19–31
53. Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B,
Mury R, Bertel O, Frielingsdorf J (2008) Proinflammatory cyto-
kines in acute myocardial infarction with and without cardiogenic
shock. Clin Res Cardiol 97:298–305
54. Reinhart K, Brunkhorst FM, Bone HG, Gerlach H, Grundling M,
Kreymann G, Kujath P, Marggraf G, Mayer K, Meier-Hellmann
A, Peckelsen C, Putensen C, Stuber F, Quintel M, Ragaller M,
Rossaint R, Weiler N, Welte T, Werdan K (2006) Diagnosis and
therapy of sepsis. Clin Res Cardiol 95:429–454
276 Clin Res Cardiol (2010) 99:267–276
123
